Janux Therapeutics CEO David Campbell's 2022 pay falls 29% to $6M
Janux Therapeutics reports 2022 executive compensation
By ExecPay News
Published: April 28, 2023
Janux Therapeutics reported fiscal year 2022 executive compensation information on April 28, 2023.
In 2022, three executives at Janux Therapeutics received on average a compensation package of $3.9M, a 30% decrease compared to previous year.
Average pay of disclosed executives at Janux Therapeutics
David Campbell, Chief Executive Officer, received $6M in total, which decreased by 29% compared to 2021. 86% of Campbell's compensation, or $5.1M, was in option awards. Campbell also received $303K in non-equity incentive plan and $550K in salary.
Byron Robinson, Chief Strategy Officer, received a compensation package of $3.4M. 82% of the compensation package, or $2.8M, was in option awards.
Wayne Godfrey, Chief Medical Officer, earned $2.3M in 2022, a 47% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 28, 2023.